openPR Logo
Press release

Global Cancer Stem Cell Clinical Trials Has More Than 35 Therapies In Pipeline

04-07-2020 01:35 PM CET | Health & Medicine

Press release from: KuicK Research

"Global Cancer Stem Cell Therapy Market, Price, Dosage & Clinical Trial Insight 2025" Report Highlights:

o Role & Mechanism Of Stem Cells In Cancer Treatment
o Stem Cell Transplantation In Cancer Treatment
o Global Bone Marrow Transplant Market Opportunity : > US$ 15 Billion
o Global Cord Blood Transplant Market Opportunity
o Cancer Stem Cell Therapy Clinical Pipeline: 37 Therapies
o Majority Stem Cells In Preclinical Phase: 18 Therapies
o Cancer Stem Cell Therapy Clinical Pipeline by Country: More Than 30 In USA
o Post Therapy Cancer Stem Cell Targeting Drugs

Download Report:,-price,-dosage-and-clinical-trial-insight-2025.php

Table of Contents

1. Introduction To Stem Cell Therapy
1.1 Overview
1.2 Historical Development

2. Stem Cells Classification
2.1 Embryonic Stem Cells
2.2 Somatic Stem Cells
2.2.1 Mesenchymal Stem Cells
2.2.2 Neural Stem Cells
2.2.3 Hematopoietic Stem Cells
2.2.4 Endothelial Progenitor Cells (EPC)
2.2.5 Cancer Stem Cells

3. Need Of Stem Cell Therapeutics

4. Advantages of Stem Cell Therapeutics

5. Role Of Stem Cells In Cancer Treatment
5.1 Stem Cell As Suicide Gene Therapy
5.2 Stem Cell As Vehicle for Oncolytic Viruses
5.3 Stem Cells In Post Cancer Treatment
5.4 Stem Cells As Nanoparticle Carriers

6. Mechanism Of Cancer Stem Cell Targeting Drug
6.1 Targeting The Molecular Signaling Pathway
6.2 Targeting Cancer Stem Cell Markers
6.3 Targeting Cancer Stem Cell Niche & Quiescent State
6.4 Targeting The miRNA Expression
6.5 Inducing Cancer Stem Cell Apoptosis
6.6 Induction Of Cancer Stem Cell Differentiation

7. Stem Cell Transplantation In Cancer Treatment
7.1 Mechanism Of Action Of Stem Cell Transplantation

7.2 Types Of Stem Cell Transplants In Cancer Treatment
7.2.1 Autologous Stem Cell Transplantation
7.2.2 Allogeneic Stem Cell Transplantation
7.2.3 Syngeneic Stem Cell Transplantation

8. Post Therapy Cancer Stem Cell Targeting Drugs
8.1 Stem Cell Therapeutics In Skin Cancer
8.1.1 Erivedge
8.1.2 Odomzo

8.2 Stem Cell Therapeutics In Leukemia
8.2.1 Daurismo

8.3 Cancer Stem Cell Therapeutics In Colon Cancer
8.3.1 Sulindac

8.4 Cancer Stem Cell Therapeutics In Breast Cancer

8.5 Stem Cell Therapeutics In Other Cancer
8.5.1 Vorinostat
8.5.2 Belinostat
8.5.3 Romidepsine
8.5.4 Panabiostat

9. Hematopoietic Stem Cell Transplant Market
9.1 Bone Marrow Transplant Market & Cost Analysis
9.2 Cord Blood Transplant Market

10. Global Cancer Stem Cell Clinical Pipeline By Company, Indication & Phase
10.1 Research
10.2 Preclinical
10.3 Phase-I
10.4 Phase-I/II
10.5 Phase-II
10.6 Phase-III

11. Global Stem Cell Therapeutics Market Analysis
11.1 Current Market Scenario
11.2 Clinical Pipeline

12. Personalized Stem Cell Cancer Therapy
12.1 Overview
12.2 Advantages of Personalized Stem Cell Cancer Therapy

13. Personalized Stem Cell Cancer Therapy by Indication
13.1 Glioblastoma
13.1.1 Lung Cancer
13.1.2 Acute Myeloid Leukemia & Melanoma
13.1.3 Ovarian & Breast Cancer
13.1.4 Pancreatic Cancer

14. Global Stem Cell Market Dynamics Challenges & Drivers
14.1 Challenges of Cancer Stem Cell Therapeutics
14.2 Global Cancer Stem Cell Therapeutics Market Drivers

15. Global Cancer Stem Cell Therapy Market Future Outlook

16. Competitive Landscape
16.1 Aelan Cell Technologies
16.2 Baylx
16.3 Benitec Biopharma
16.4 BlueRock Therapeutics
16.5 Calidi Biotherapeutics
16.6 Cellular Dynamics International
16.7 Center for iPS Cell Research and Application
16.8 Century Therapeutics
16.9 Khloris Biosciences
16.10 ReNeuron

Neeraj Chawla


Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Stem Cell Clinical Trials Has More Than 35 Therapies In Pipeline here

News-ID: 2001912 • Views: 541

More Releases from KuicK Research

Global Peptide Cancer Drug Oncology Therapeutics Market Clinical Trial Report 20 …
"Global Peptide Cancer Therapeutics Market, Drug Dosage, Price and Clinical Trials Insight 2026" Report highlights: • Global cancer Peptide Market Opportunity: > US$ 20 Billion By 2026 • Price, Dosage, Sales Insight On 22 Marketed Cancer Peptides • Global Peptide Cancer Therapeutics Clinical Trials Overview by Company, Country, Indication, Phase & Formulation • Comprehensive Clinical Insight On More Than 150 Cancer Peptides In Clinical Trials • Comprehensive Clinical Insight On More Than 20 Cancer Peptides Available In Market • Application of
Global Cancer Immunotherapy Market Opportunity Market Size Clinial Pipeline Tria …
The research report "Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" aims at providing a comprehensive analysis about the overall market trends in the global cancer immunotherapy market. The report also discusses the insights of the various methodologies that the therapy has presented over the last few decades. In addition to the recent appreciation that the therapy is gaining in the market, the report also covers
Global Cancer Generics Drug Market Pricing Dosage Size Insight By Countries Drug …
The research report "Global Cancer Generics Market, Drug Dosage, Price and Opportunity Insight 2026" provides a comprehensive view about the recent trends and opportunities that are followed by the market at the level of regional and global. The study majorly focuses on the strategies that have been adopted by several players in revolutionizing the market and making the clinicians and non-clinicians more inclined towards adopting generic drugs. In addition to
Corona Virus Covid19 Drugs Vaccine Clinical Trials Surpass 100 Vaccine Globally
"Global Coronavirus COVID 19 Clinical Trials Insight 2020" Report Highlight: o Number Of Drugs In Clinical Trials: >70 Drugs o Majority Of Drugs in Research Phase: > 30 Drugs o USA & China Dominating Clinical Trials: >20 Drugs o Vaccines Accounts Major Share In Clinical Trials: >10 Vaccines o Expected Market Opportunity: > US$ 1 Billion The research report "Global Coronavirus COVID 19 Clinical Trials Insight 2020" discusses about the recent outbreak of coronavirus that has badly affected

All 5 Releases